Robotic Thoracic Surgery

Transform minimally invasive surgery with da Vinci lobectomy, segmentectomy, wedge resection and other thoracic and foregut procedures

Advancing what’s possible in lung cancer care and robotic thoracic surgery

Thoracic surgery is complex and demanding. In every chest procedure, you face the challenges of operating within constrained spaces in and around critical structures while minimizing the risk of complications.

The da Vinci surgical system has opened up the possibilities for minimally invasive thoracic surgery and is the leading modality 1 for lobectomy in the U.S. With SureForm stapling, Firefly fluorescence imaging, and your choice of wristed instruments, you can navigate the thoracic cavity and perform a range of procedures with flexibility.

With the Ion robotic bronchoscopy system, Intuitive is uniquely equipped to help you transform lung cancer care. Intuitive’s technologies span diagnosis to intervention and are connected by a digital ecosystem that transforms your robotic performance data into actionable insights.

Learn how Dr. Ross thinks thoracic oncology programs can benefit from using da Vinci and Ion in tandem to enhance lung cancer care. And see how the da Vinci system enables Drs. Servais, Soukiasian, Cerfolio, and Oh to perform lung resection and esophagectomy.

Peers on the frontier of thoracic surgery and thoracic oncology programming

Tune into Intuitive’s Chest Channel, a peer-to-peer learning series dedicated to supporting thoracic surgeons in their pursuit of excellence throughout their careers. Hear directly from other surgeons about their experiences with the comprehensive Intuitive ecosystem of systems, learning and services, connected by digital insights.

Get the latest tips on techniques, expanding your practice, and building a thoracic oncology program with Intuitive. Topics include surgeons’ experiences with incorporating both da Vinci Xi and Ion into a practice, performing technically challenging procedures, such as complex segmentectomies, and progressing through the da Vinci learning curve.

Recent clinical evidence for da Vinci lobectomy

Thoracic surgeons’ continued adoption of da Vinci systems has yielded a substantial body of peer-reviewed evidence, exceeding 1,900 publications. The literature demonstrates a record of positive clinical outcomes2 for da Vinci lobectomy, and that record continues to grow.

Improving lobectomy outcomes with da Vinci

A landmark study evaluates outcomes for da Vinci robotic-assisted, video-assisted thorascopic (VATS) and open lobectomy, including length of hospital stay, operative time, and conversion rate.

Analyzing the perioperative cost of lobectomy

A propensity-score matched study compares the outcomes and 30-day perioperative cost of da Vinci robotic, VATS, and open lobectomy.

Exploring opioid administration after lobectomy

See a propensity-score matched analysis of opioid administration following da Vinci robotic, VATS, and open lobectomy.

Evaluating robotic stapling in da Vinci lobectomy

A propensity-score matched study reviews the association of robotic stapling with outcomes such as air leak rate and hospitalization cost in da Vinci lobectomy.

Intuitive innovations for your practice

We don’t just build robots. We design holistic solutions. Over the years, we’ve created a comprehensive ecosystem of systems, learning and services, connected by digital insights, that helps you advance what’s possible in minimally invasive care.

Your channel for current topics in thoracic oncology and da Vinci surgery

Tune into the Chest Channel to get the latest surgeon insights on da Vinci lobectomy, segmentectomy, wedge resection, and more. Learn about thoracic oncology program excellence.
  1. As of Q4 2020 based on internal analysis of Premier Healthcare Database. Data have not been peer-reviewed or published and may or may not be reproducible or generalizable.
  2. An internal meta-analysis showed lobectomy using the da Vinci® surgical system was associated with shorter length of stay, lower conversion rates to open surgery, and lower 30-day readmission and mortality rates than VATS lobectomy. This summary of clinical results reflects an Intuitive internal pooled meta-analysis of 30 peer-reviewed robotic lobectomy publications. The analysis showed lobectomy with the da Vinci was associated with longer operative time than VATS lobectomy, and comparable lymph node yield and rates of 30-day postoperative complications, 30-day reoperations, blood transfusions, nodal upstaging, positive surgical margins to VATS lobectomy. Meta-analysis is on file.
  3. Comparisons of reach are relative to manual bronchoscopes. Reach is defined by airway generation access. Comparisons of precision and stability are relative to manual techniques. Precision is the ability to place a biopsy tool in a desired location consistently. Stability is enabled by fiber optic sensing technology which maintains active robotic control of catheter position and corrects unwanted tip deflection. Results based on internal testing.
  4. ~25% of SureForm stapler fires are at an angle of articulation beyond the capabilities of standard laparoscopic staplers. Intuitive analysis of procedures completed between April 29, 2021 and April 28, 2023.